LISATA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
LISATA THERAPEUTICS, INC. (LSTA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $6.83 per share as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $6.83.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $6.24.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $6.51.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $6.51.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $6.83 10-Q · filed 2026-08-06 |
| 2026-03-31 | $6.24 10-Q · filed 2026-05-11 |
| 2025-12-31 | $6.51 10-K · filed 2026-03-12 |
| 2025-09-30 | $6.51 10-Q · filed 2025-11-06 |
| 2025-06-30 | $6.50 10-Q · filed 2025-08-07 |
| 2025-03-31 | $6.60 10-Q · filed 2025-05-08 |
| 2024-12-31 | $9.52 10-K · filed 2025-02-27 |
| 2024-09-30 | $9.46 10-Q · filed 2024-11-12 |
| 2024-06-30 | $9.92 10-Q · filed 2024-08-12 |
| 2024-03-31 | $9.92 10-Q · filed 2024-05-09 |
| 2023-12-31 | $11.25 10-K · filed 2024-02-29 |
| 2023-09-30 | $11.25 10-Q · filed 2023-11-02 |
| 2023-06-30 | $11.02 10-Q · filed 2023-08-14 |
| 2023-03-31 | $10.90 10-Q · filed 2023-05-09 |
| 2022-12-31 | $11.60 10-K · filed 2023-03-30 |
| 2022-09-30 | $11.82 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.92 10-Q · filed 2022-08-04 |
| 2022-03-31 | $7.36 10-Q · filed 2022-05-05 |
| 2021-12-31 | $9.26 10-K · filed 2022-03-22 |
| 2020-12-31 | $18.42 10-K · filed 2021-02-25 |
| 2019-12-31 | $22.41 10-K · filed 2020-03-05 |
| 2011-12-31 | $1.82 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |